GLORIA G GUPTILL
Allopathic & Osteopathic Physicians|Internal Medicine DELMAR, NY NPI 1295994002
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine NY ABBVIE INC. All categories
General Payments — all program years on this page
$4,166.51
- Category: General Payments
- Program years: PY2018–2024
- Record count: 268
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,041.28 across 57 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,041.28 | 57 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $240.86 | 10 |
| GlaxoSmithKline, LLC. | $179.14 | 14 |
| Astellas Pharma US Inc | $74.23 | 4 |
| SANOFI-AVENTIS U.S. LLC | $67.95 | 2 |
| Novo Nordisk AS | $64.37 | 3 |
| Acerta Pharma LLC | $56.76 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $51.49 | 3 |
| Lilly USA, LLC | $42.70 | 2 |
| Alnylam Pharmaceuticals Inc. | $40.05 | 2 |
| Abbott Laboratories | $35.12 | 2 |
| PFIZER INC. | $31.06 | 2 |
| Exact Sciences Corporation | $30.68 | 2 |
| Sumitomo Pharma America, Inc. | $29.48 | 2 |
| E.R. Squibb & Sons, L.L.C. | $20.54 | 1 |
| Averitas Pharma Inc. | $17.48 | 1 |
| OptiNose US, Inc. | $16.43 | 1 |
| Xeris Pharmaceuticals, Inc. | $14.45 | 1 |
| Amgen Inc. | $14.25 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $14.24 | 1 |
By program year
Records — PY2024 (57)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.